Meningococcal Vaccines Market

Meningococcal Vaccines Market by Product, Age Group, Distribution Channel & Region - Forecast 2022 – 2032

Market Insights on Meningococcal Vaccines covering sales outlook, demand forecast and up-to-date key trends

Request Sample

Meningococcal Vaccines Market Outlook (2022-2032)

[312 Pages Report] Global meningococcal vaccines market is set to expand at a 8.6% CAGR over the forecast period, reaching US$ 3.4 Bn in 2022. As per Future Market Insights (FMI), in terms of revenue, conjugate vaccines segment dominated the market with 62.6% revenue share in 2021.

Data Points	Market Insights
Meningococcal Vaccines Market Base Year Value (2021)	US$ 3.1 Bn
Estimated Market Size (2022)	US$ 3.4 Bn
Projected Market Valuation (2032)	US$ 7.7 Bn
Value-based CAGR (2022-2032)	8.6%
Market Share of Top 5 Countries	65.9%

Rising prevalence of meningitis, growing demand for permanent cure of meningitis and private-public partnerships to provide funding for immunization programs are some factors that are expected to create opportunities for growth in the market.

Bacterial meningitis, also known as cerebrospinal meningitis, is more aggressive and can lead to permanent damage or death. Survivors of bacterial meningitis may suffer from long-term effects including hearing loss, brain damage, memory loss, learning difficulties, or even septicaemia.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

How The Market Progressed Till June 2022?

Particulars	Details
H1, 2021	9.20%
H1, 2022 Projected	8.65%
H1, 2022 Outlook	8.15%
BPS Change - H1, 2022 (O) – H1, 2022 (P)	(-) 50 ↓
BPS Change – H1, 2022 (O) – H1, 2021	(-) 105 ↓

Comparative and review analysis of market dynamics for the meningococcal vaccines market by Future Market Insights revealed that H1-2022 outlook period in comparison to H1-2022 will project a negative growth in terms of Basis Point Share by 50 BPS. However, In H1-2022, the market growth rate of meningococcal vaccines is expected to fall by nearly 105 basis point share (BPS), as per FMI analysis.

A cost-effective vaccine would ideally only need a limited number of doses, be safe for infants, cover most of the pathogenic serogroups, be economically accessible, and offer lifetime immunity. Unfortunately, none of the vaccinations that are currently on the market satisfy these requirements.

Meningococcal polysaccharide vaccines (MPSV) and meningococcal polysaccharide-protein conjugated vaccines (MCV) are currently the only vaccinations for invasive meningococcal disease. MPSV have a number of drawbacks that make the adoption of MCV more advantageous.

First off, due to their low immunogenicity and high disease burden, MPSV are ineffective in younger children (less than 2 years), who have the highest incidence of disease.

Second, they are unable to give long-term immunity since, according to new evidence from a Cochrane review, immunity after the first year of immunisation is not well established. These disadvantages present a restraint towards the market values for meningococcal vaccines, and hence the associated BPS values.

2017-2021 Meningococcal Vaccines Market Historic Outlook Vs 2022-2032 Forecast

The market value for meningococcal vaccines accounted for nearly 5.3% of the overall US$ 59 Bn global vaccines market in 2021.

Threat of pandemic meningitis outbreaks drive investment by government and manufacturers that will propel the demand for meningococcal vaccines in the forthcoming years. Meningococcal outbreak is a public health challenge, especially meningococcal meningitis. The disease is associated with high rate of mortality and long-term neurological defects among infants and children.

Majority of developing countries, including BRICS are taking steps to initiate the development and production of meningococcal vaccines. This is creating significant opportunities for multinational companies to invest in the vaccine production. For instance, ABIVAX Société Anonyme, a French biotechnology company, collaborated with Latin American meningococcal vaccine manufacturer Finlay institute of vaccines in 2014 to commercialize meningococcal vaccines.

Meningococcal vaccinations that are being included in national immunisation programmes will assure a long-term and inexpensive supply of vaccines for both the public and private sectors. For instance, in July, 2020 GSK Australia given Meningococcal B (MenB) vaccination for Aboriginal and Torres Strait Islander infants to the National Immunization Program (NIP).

With the help of global partners such as the World Health Organization (WHO) and the United Nations Children's Fund, vaccines are now being administered more quickly in low-income countries such as Africa. Expanding vaccine access in these underserved markets will augment the growth in the market.

According to the WHO vaccination coverage statistics, nearly 250 million Africans were immunised against meningococcal disease within six years of the vaccine's introduction. By the end of 2020, MenAfriVac will have vaccinated nearly 350 million people in 24 of the 26 nations in the meningitis belt.

The market is expected to expand at a 8.6% CAGR over the forecast period, offering an absolute $ opportunity of US$ 273.4 Mn.

Meningococcal Vaccines Market

What are the Key Opportunities for Meningococcal Vaccines Manufacturers?

Creating stable vaccine supply in emerging countries provides enormous growth opportunities for manufacturers of meningococcal vaccines. To ensure steady supply, manufacturers must look for high-quality manufacturing capacities to fulfil the unmet demand.

To respond effectively to emergency outbreaks of infectious diseases such as meningococcal disease, collaboration across many parties to develop and assess vaccines, as well as innovative supply and funding models, is becoming increasingly vital. As a result, firms have a great opportunity to enter this market to meet the unmet need for meningococcal vaccinations.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Factors Restraining Demand for Meningococcal Vaccines?

Factors restraining the demand for meningococcal vaccines include limited supply and dependency on few manufacturers. Manufacturer’s access is limited by country’s capacity to support immunization and unawareness among general population. There exists a vast difference in coverage of established and new vaccines, primarily due to low awareness among general population.

Demand of meningococcal vaccines mainly depends on disease outbreaks, funding decisions, adoption by NIP, regulatory scenarios, and competing vaccine introduction priorities. Besides this, manufacturers’ access to certain markets is restricted by the differential pricing strategies adopted by government of developing countries, which further restricts the penetration of newly approved/launched vaccine products.

Country-wise Insights

What is Driving the U.S. Meningococcal Vaccines Market?

“Surging Demand for Meningitis Vaccines in the U.S. will Augment Growth”

The U.S. leads the North America meningococcal vaccine market, accounting for about 94.0% of the total market share in 2021, and is estimated to show the high growth through the forecast period. Expansion in the healthcare sector, along with growing FDA approvals for vaccines and novel drugs in the U.S. will bode well for the market over the forecast period.

For example, the United States Food and Drug Administration (FDA) authorised PREVNAR 20, Pfizer's Pneumococcal 20-valent Conjugate Vaccine, for individuals aged 18 and above, in June 2021. In addition to this, the vaccine includes capsular polysaccharide conjugates for seven additional serotypes that cause invasive pneumococcal disease (IPD) and have been linked to high case fatality rates, antibiotic resistance, and/or meningitis.

Why is the U.K. Meningococcal Vaccines Market Considered Lucrative?

“Rising Prevalence of Meningococcal Disease in the U.K. Will Fuel Sales”

Demand in the U.K. is set to increase at a CAGR of 9.8% in the Europe meningococcal vaccines market during the forecast period. The coverage for immunization with meningococcal vaccines is as high as 90% in infants and 85% in children and adults in the country, which provides an opportunity for manufacturers to introduce their products in the market.

How is the China Meningococcal Vaccines Market Faring?

“Increasing Sales of Meningococcal B Vaccines in China Will Steer Growth”

China accounted for 50.7% of the East Asia meningococcal market share in 2021. High birth rate in China and rising prevalence of meningitis is underpinning the demand for meningococcal vaccines.

According to 2021 figures, the yearly incidence of meningococcal illness and carriage in China was 0.0017–0.0183 per 100,000 people in 2021. Incidence is highest in children under the age of one year, with a case fatality rate of 5.45 percent in 2021. Serogroup B has the highest rate of occurrence.

Category-wise Insights

Which Meningococcal Vaccines Product is Driving the Market?

“Sales of Conjugate Vaccines to Remain High”

Based on product type, the conjugate vaccines segment accounted for 62.6% of the total market share in 2021, owing to its advanced technological features and high adoption rates by end users. Weak antigen and vaccines are combined and linked to a strong antigen as a carrier. This can give strong immune response to weak antigen. This factor is expected to drive sales in the market over the forecast period.

Which is the Leading Age Group in the Meningococcal Vaccines Market?

“Demand for Meningococcal Vaccines Among Adolescents Will Gain Traction”

In terms of age group, sales in the adolescents & young adults segment are expected to grow at a CAGR of 7.6% over the assessment period. The segment accounted for about 30.5% of the total market share in 2021.

The metrics are valued as per the disease aggravation. This age group is more prone to meningococcal bacterial infection with life threating issues. In order to prevent the above mentioned factors, young adults have a higher adoption of meningococcal vaccines.

Which Distribution Channel Benefits the Most in the Meningococcal Vaccines Market?

“Adoption of Meningococcal Vaccines Across Public Health Agencies Will Gain Momentum”

By distribution channel, public health agencies held about 38.1% of the total market share in 2021. Public health agencies have a large foot fall for all kinds of vaccines. Also, companies are focusing on unique strategies for distribution of vaccines across public health agencies.

Competitive Landscape

Key players operating in the global meningococcal vaccines market are focusing on the development and launch with regulatory approvals for meningococcal vaccines. Established players within the industry are focusing on mergers and acquisitions for improving their global presence. For instance:

In August 2020, GlaxoSmithKline plc commenced patient dosing in a phase III clinical study comparing its 5-in-1 meningitis (MenABCWY) vaccine candidate against licenced meningococcal vaccines, Bexsero and Menveo.
MenQuadfi was authorised by the European Commission (EC) in November 2020 for active vaccination of people aged 12 months and up against invasive meningococcal illness caused by Neisseria meningitis serogroups A, C, W, and Y.

Report Scope as per Meningococcal Vaccines Industry Analysis

Attribute	Details
Estimated Market Size (2022)	US$ 3.4 Bn
Projected Market Valuation (2032)	US$ 7.7 Bn
Value-based CAGR (2022-2032)	8.6%
Forecast Period	2022-2032
Historical Data Available for	2017-2021
Market Analysis	US$ Bn for Value
Key Regions Covered	North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa
Key Countries Covered	The U.S., Canada, Brazil, Mexico, Germany, the U.K., France, Italy, Spain, Russia, Poland, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, GCC Countries, Turkey, South Africa and North Africa
Key Market Segments Covered	Product, Age Group, Distribution Channel and Region
Key Companies Profiled	Pfizer Inc. GlaxoSmithKline plc. Sanofi SA Serum Institute of India Walvax Biotechnology Co., Ltd. Incepta Pharmaceuticals Limited Hualan Biological Engineering Inc.

Key Market Segments Covered in Meningococcal Vaccines Industry Research

By Product:

Polysaccharide
Conjugate

By Age Group:

Infants
Children
Adolescents & young Adults
Adults

By Distribution Channel:

Pharmacies
Community Clinics
Public Health Agencies
Others (hospital pharmacy, private market etc.)

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

Frequently Asked Questions

How much is the meningococcal vaccines market currently worth?

The global meningococcal vaccines market is worth US$ 3.4 Bn in 2022 and is set to expand 2.3X over the forecast period.

What is the sales forecast for meningococcal vaccines through 2032?

The meningococcal vaccines market is expected to reach US$ 7.7 Bn by the end of 2032, with sales growing at a 8.6% CAGR.

What are the key trends shaping the meningococcal vaccines industry?

Expansion of product indications, and increasing pharmacy-based immunization services, are some of the key trends being witnessed in this marketplace.

Which are the top 5 countries driving demand for meningococcal vaccines?

The U.S., the U.K., China, France, and Japan are expected to drive demand for meningococcal vaccines products.

What is the North America market outlook for meningococcal vaccines?

North America is one of the key markets for meningococcal vaccines, with the U.S. expected to account over 94.0% of the North American market in 2021.

At what percentage is the demand for meningococcal vaccines expected to register growth in Europe?

Demand for meningococcal vaccines in Europe is expected to register growth of 8.6% over the next ten years.

Which are the key exporters of meningococcal vaccines market?

Pfizer Inc., Sanofi SA, GSK are the key exporters of meningococcal vaccines market.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Key Trends Impacting the Market

4. Key Success Factors

4.1. Disease Epidemiology

4.2. Pipeline Assessment

4.3. Parent Market Analysis

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global GDP Growth Outlook

5.1.2. Global Healthcare GDP Growth Overview

5.1.3. Shift Towards Value-Based Healthcare Model

5.1.4. The Most Considered Factor By Companies in Vaccine Pricing

5.1.5. Global Biotechnology Mergers and Acquisition Overview

5.2. Forecast Factors - Relevance & Impact

5.2.1. Global Increase in Healthcare Expenditure

5.2.2. Expanding Product Indications

5.2.3. Endemic outbreaks of Meningococcal disease

5.2.4. Prevalence of Meningococcal disease

5.2.5. Product Penetration Rate across End Users

5.2.6. New/Improved Product Launches

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunity Analysis

6. COVID-19-19 Crisis – Impact Assessment

6.1. COVID-19 Impact-2021 Market Outlook

6.2. Short-Mid-Long Term Outlook

7. Global Market Demand (in Value or Size in US$ Bn) Analysis 2017–2021 and Forecast, 2022–2032

7.1. Historical Market Value (US$ Bn) Analysis, 2017–2021

7.2. Current and Future Market Value (US$ Bn) Projections, 2022–2032

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2017–2021 and Forecast 2022–2032, By Product Type

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Bn) Analysis By Product Type, 2017–2021

8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Product Type, 2022–2032

8.3.1. Polysaccharide Vaccines

8.3.2. Conjugate Vaccines

8.4. Market Attractiveness Analysis By Product Type

9. Global Market Analysis 2017–2021 and Forecast 2022–2032, By Age Group

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Bn), By Age Group, 2017–2021

9.3. Current and Future Market Size (US$ Bn) and Forecast By Age Group, 2022–2032

9.3.1. Infants

9.3.2. Children

9.3.3. Adolescents & young Adults

9.3.4. Adults

9.4. Market Attractiveness Analysis By Age Group

10. Global Market Analysis 2017–2021 and Forecast 2022–2032, By Distribution Channel

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Bn), By Distribution Channel, 2017–2021

10.3. Current and Future Market Size (US$ Bn) and Forecast By Distribution Channel, 2022–2032

10.3.1. Pharmacies

10.3.2. Community Clinics

10.3.3. Public Health Agencies

10.3.4. Others (hospital pharmacy, private market etc.)

10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Market Analysis 2017–2021 and Forecast 2022–2032, by Region

11.1. Introduction

11.2. Historical Market Size (US$ Bn) Analysis By Region, 2017–2021

11.3. Current Market Size (US$ Bn) Analysis and Forecast By Region, 2022–2032

11.3.1. North America

11.3.2. Latin America

11.3.3. Europe

11.3.4. East Asia

11.3.5. South Asia

11.3.6. Oceania

11.3.7. Middle East and Africa (MEA)

11.4. Market Attractiveness Analysis By Region

12. North America Market Analysis 2017–2021 and Forecast 2022–2032

12.1. Introduction

12.2. Historical Market Size (US$ Bn) and Trend Analysis By Market Taxonomy, 2017–2021

12.3. Market Size (US$ Bn) Forecast By Market Taxonomy, 2022–2032

12.3.1. By Country

12.3.1.1. U.S.

12.3.1.2. Canada

12.3.2. By Product Type

12.3.3. By Age Group

12.3.4. By Distribution Channel

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Product Type

12.4.3. By Age Group

12.4.4. By Distribution Channel

12.5. Key Market Participants - Intensity Mapping

12.6. Drivers and Restraints - Impact Analysis

12.7. Country Level Analysis & Forecast

12.7.1. U.S. Market Analysis

12.7.1.1. Introduction

12.7.1.2. Market Analysis and Forecast by Market Taxonomy

12.7.1.2.1. By Product Type

12.7.1.2.2. By Age Group

12.7.1.2.3. By Distribution Channel

12.7.2. Canada Market Analysis

12.7.2.1. Introduction

12.7.2.2. Market Analysis and Forecast by Market Taxonomy

12.7.2.2.1. By Product Type

12.7.2.2.2. By Age Group

12.7.2.2.3. By Distribution Channel

13. Latin America Market Analysis 2017–2021 and Forecast 2022–2032

13.1. Introduction

13.2. Historical Market Size (US$ Bn) and Trend Analysis By Market Taxonomy, 2017–2021

13.3. Market Size (US$ Bn) Forecast By Market Taxonomy, 2022–2032

13.3.1. By Country

13.3.1.1. Mexico

13.3.1.2. Brazil

13.3.1.3. Argentina

13.3.1.4. Rest of Latin America

13.3.2. By Product Type

13.3.3. By Age Group

13.3.4. By Distribution Channel

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Product Type

13.4.3. By Age Group

13.4.4. By Distribution Channel

13.5. Key Market Participants - Intensity Mapping

13.6. Drivers and Restraints - Impact Analysis

13.7. Country Level Analysis & Forecast

13.7.1. Mexico Market Analysis

13.7.1.1. Introduction

13.7.1.2. Market Analysis and Forecast by Market Taxonomy

13.7.1.2.1. By Product Type

13.7.1.2.2. By Age Group

13.7.1.2.3. By Distribution Channel

13.7.2. Brazil Market Analysis

13.7.2.1. Introduction

13.7.2.2. Market Analysis and Forecast by Market Taxonomy

13.7.2.2.1. By Product Type

13.7.2.2.2. By Age Group

13.7.2.2.3. By Distribution Channel

13.7.3. Argentina Market Analysis

13.7.3.1. Introduction

13.7.3.2. Market Analysis and Forecast by Market Taxonomy

13.7.3.2.1. By Product Type

13.7.3.2.2. By Age Group

13.7.3.2.3. By Distribution Channel

13.7.4. Rest of the Latin America Market Analysis

13.7.4.1. Introduction

13.7.4.2. Market Analysis and Forecast by Market Taxonomy

13.7.4.2.1. By Product Type

13.7.4.2.2. By Age Group

13.7.4.2.3. By Distribution Channel

14. Europe Market Analysis 2017–2021 and Forecast 2022–2032

14.1. Introduction

14.2. Historical Market Size (US$ Bn) and Trend Analysis By Market Taxonomy, 2017–2021

14.3. Market Size (US$ Bn) Forecast By Market Taxonomy, 2022–2032

14.3.1. By Country

14.3.1.1. Germany

14.3.1.2. Italy

14.3.1.3. France

14.3.1.4. U.K.

14.3.1.5. Spain

14.3.1.6. Poland

14.3.1.7. Russia

14.3.1.8. Rest of Europe

14.3.2. By Product Type

14.3.3. By Age Group

14.3.4. By Distribution Channel

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Product Type

14.4.3. By Age Group

14.4.4. By Distribution Channel

14.5. Key Market Participants - Intensity Mapping

14.6. Drivers and Restraints - Impact Analysis

14.7. Country Level Analysis & Forecast

14.7.1. Germany Market Analysis

14.7.1.1. Introduction

14.7.1.2. Market Analysis and Forecast by Market Taxonomy

14.7.1.2.1. By Product Type

14.7.1.2.2. By Age Group

14.7.1.2.3. By Distribution Channel

14.7.2. Italy Market Analysis

14.7.2.1. Introduction

14.7.2.2. Market Analysis and Forecast by Market Taxonomy

14.7.2.2.1. By Product Type

14.7.2.2.2. By Age Group

14.7.2.2.3. By Distribution Channel

14.7.3. France Market Analysis

14.7.3.1. Introduction

14.7.3.2. Market Analysis and Forecast by Market Taxonomy

14.7.3.2.1. By Product Type

14.7.3.2.2. By Age Group

14.7.3.2.3. By Distribution Channel

14.7.4. U.K. Market Analysis

14.7.4.1. Introduction

14.7.4.2. Market Analysis and Forecast by Market Taxonomy

14.7.4.2.1. By Product Type

14.7.4.2.2. By Age Group

14.7.4.2.3. By Distribution Channel

14.7.5. Spain Market Analysis

14.7.5.1. Introduction

14.7.5.2. Market Analysis and Forecast by Market Taxonomy

14.7.5.2.1. By Product Type

14.7.5.2.2. By Age Group

14.7.5.2.3. By Distribution Channel

14.7.6. Poland Market Analysis

14.7.6.1. Introduction

14.7.6.2. Market Analysis and Forecast by Market Taxonomy

14.7.6.2.1. By Product Type

14.7.6.2.2. By Age Group

14.7.6.2.3. By Distribution Channel

14.7.7. Russia Market Analysis

14.7.7.1. Introduction

14.7.7.2. Market Analysis and Forecast by Market Taxonomy

14.7.7.2.1. By Product Type

14.7.7.2.2. By Age Group

14.7.7.2.3. By Distribution Channel

15. South Asia Market Analysis 2017–2021 and Forecast 2022–2032

15.1. Introduction

15.2. Historical Market Size (US$ Bn) and Trend Analysis By Market Taxonomy, 2017–2021

15.3. Market Size (US$ Bn) Forecast By Market Taxonomy, 2022–2032

15.3.1. By Country

15.3.1.1. India

15.3.1.2. Indonesia

15.3.1.3. Malaysia

15.3.1.4. Thailand

15.3.1.5. Rest of South Asia

15.3.2. By Product Type

15.3.3. By Age Group

15.3.4. By Distribution Channel

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Product Type

15.4.3. By Age Group

15.4.4. By Distribution Channel

15.5. Key Market Participants - Intensity Mapping

15.6. Drivers and Restraints - Impact Analysis

15.7. Country Level Analysis & Forecast

15.7.1. India Market Analysis

15.7.1.1. Introduction

15.7.1.2. Market Analysis and Forecast by Market Taxonomy

15.7.1.2.1. By Product Type

15.7.1.2.2. By Age Group

15.7.1.2.3. By Distribution Channel

15.7.2. Indonesia Market Analysis

15.7.2.1. Introduction

15.7.2.2. Market Analysis and Forecast by Market Taxonomy

15.7.2.2.1. By Product Type

15.7.2.2.2. By Age Group

15.7.2.2.3. By Distribution Channel

15.7.3. Malaysia Market Analysis

15.7.3.1. Introduction

15.7.3.2. Market Analysis and Forecast by Market Taxonomy

15.7.3.2.1. By Product Type

15.7.3.2.2. By Age Group

15.7.3.2.3. By Distribution Channel

15.7.4. Thailand Market Analysis

15.7.4.1. Introduction

15.7.4.2. Market Analysis and Forecast by Market Taxonomy

15.7.4.2.1. By Product Type

15.7.4.2.2. By Age Group

15.7.4.2.3. By Distribution Channel

15.7.5. Rest of South Asia Market Analysis

15.7.5.1. Introduction

15.7.5.2. Market Analysis and Forecast by Market Taxonomy

15.7.5.2.1. By Product Type

15.7.5.2.2. By Age Group

15.7.5.2.3. By Distribution Channel

16. East Asia Market Analysis 2017–2021 and Forecast 2022–2032

16.1. Introduction

16.2. Historical Market Size (US$ Bn) and Trend Analysis By Market Taxonomy, 2017–2021

16.3. Market Size (US$ Bn) Forecast By Market Taxonomy, 2022–2032

16.3.1. By Country

16.3.1.1. China

16.3.1.2. Japan

16.3.1.3. South Korea

16.3.2. By Product Type

16.3.3. By Age Group

16.3.4. By Distribution Channel

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Product Type

16.4.3. By Age Group

16.4.4. By Distribution Channel

16.5. Key Market Participants - Intensity Mapping

16.6. Drivers and Restraints - Impact Analysis

16.7. Country Level Analysis & Forecast

16.7.1. China Market Analysis

16.7.1.1. Introduction

16.7.1.2. Market Analysis and Forecast by Market Taxonomy

16.7.1.2.1. By Product Type

16.7.1.2.2. By Age Group

16.7.1.2.3. By Distribution Channel

16.7.2. Japan Market Analysis

16.7.2.1. Introduction

16.7.2.2. Market Analysis and Forecast by Market Taxonomy

16.7.2.2.1. By Product Type

16.7.2.2.2. By Age Group

16.7.2.2.3. By Distribution Channel

16.7.3. South Korea Market Analysis

16.7.3.1. Introduction

16.7.3.2. Market Analysis and Forecast by Market Taxonomy

16.7.3.2.1. By Product Type

16.7.3.2.2. By Age Group

16.7.3.2.3. By Distribution Channel

17. Oceania Market 2017-2021 and Forecast 2022-2032

17.1. Introduction

17.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2017–2021

17.3. Market Size (US$ Bn) Forecast By Market Taxonomy, 2022–2032

17.3.1. By Country

17.3.1.1. Australia

17.3.1.2. New Zealand

17.3.2. By Product Type

17.3.3. By Age Group

17.3.4. By Distribution Channel

17.4. Market Attractiveness Analysis

17.4.1. By Country

17.4.2. By Product Type

17.4.3. By Age Group

17.4.4. By Distribution Channel

17.5. Key Market Participants - Intensity Mapping

17.6. Drivers and Restraints - Impact Analysis

17.7. Country Level Analysis & Forecast

17.7.1. Australia Market Analysis

17.7.1.1. Introduction

17.7.1.2. Market Analysis and Forecast by Market Taxonomy

17.7.1.2.1. By Product Type

17.7.1.2.2. By Age Group

17.7.1.2.3. By Distribution Channel

17.7.2. New Zealand Market Analysis

17.7.2.1. Introduction

17.7.2.2. Market Analysis and Forecast by Market Taxonomy

17.7.2.2.1. By Product Type

17.7.2.2.2. By Age Group

17.7.2.2.3. By Distribution Channel

18. Middle East and Africa (MEA) Market Analysis 2017–2021 and Forecast 2022–2032

18.1. Introduction

18.2. Historical Market Size (US$ Bn) and Trend Analysis By Market Taxonomy, 2017–2021

18.3. Market Size (US$ Bn) Forecast By Market Taxonomy, 2022–2032

18.3.1. By Country

18.3.1.1. GCC Countries

18.3.1.2. South Africa

18.3.1.3. Rest of Middle East and Africa

18.3.2. By Product Type

18.3.3. By Age Group

18.3.4. By Distribution Channel

18.4. Market Attractiveness Analysis

18.4.1. By Country

18.4.2. By Product Type

18.4.3. By Age Group

18.4.4. By Distribution Channel

18.5. Key Market Participants - Intensity Mapping

18.6. Drivers and Restraints - Impact Analysis

18.7. Country Level Analysis & Forecast

18.7.1. GCC Countries Market Analysis

18.7.1.1. Introduction

18.7.1.2. Market Analysis and Forecast by Market Taxonomy

18.7.1.2.1. By Product Type

18.7.1.2.2. By Age Group

18.7.1.2.3. By Distribution Channel

18.7.2. South Africa & North Africa Market Analysis

18.7.2.1. Introduction

18.7.2.2. Market Analysis and Forecast by Market Taxonomy

18.7.2.2.1. By Product Type

18.7.2.2.2. By Age Group

18.7.2.2.3. By Distribution Channel

18.7.3. Rest of MEA Market Analysis

18.7.3.1. Introduction

18.7.3.2. Market Analysis and Forecast by Market Taxonomy

18.7.3.2.1. By Product Type

18.7.3.2.2. By Age Group

18.7.3.2.3. By Distribution Channel

19. Market Structure Analysis

19.1. Market Analysis by Tier of Companies

19.2. Market Share Analysis of Top Players

20. Competition Analysis

20.1. Competition Dashboard

20.2. Competition Deep Dive

20.2.1. Pfizer Inc.

20.2.1.1. Overview

20.2.1.2. Product Portfolio

20.2.1.3. Key Financials

20.2.1.4. Sales Footprint

20.2.1.5. Strategy Overview

20.2.2. GlaxoSmithKline plc.

20.2.2.1. Overview

20.2.2.2. Product Portfolio

20.2.2.3. Key Financials

20.2.2.4. Sales Footprint

20.2.2.5. Strategy Overview

20.2.3. Sanofi SA

20.2.3.1. Overview

20.2.3.2. Product Portfolio

20.2.3.3. Key Financials

20.2.3.4. Sales Footprint

20.2.3.5. Strategy Overview

20.2.4. Serum Institute of India

20.2.4.1. Overview

20.2.4.2. Product Portfolio

20.2.4.3. Key Financials

20.2.4.4. Sales Footprint

20.2.4.5. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology

List of Tables

Table 01: Global Market Value (US$ Bn) Analysis- and Opportunity Assessment 2017–2032, By Product Type

Table 02: Global Market Value (US$ Bn) Analysis and Opportunity Assessment 2017–2032, By Age Group

Table 03: Global Market Value (US$ Bn) Analysis- and Opportunity Assessment 2017–2032, By Distribution Channel

Table 04: Global Market Value (US$ Bn) Analysis and Opportunity Assessment 2017–2032, By Country

Table 05: North America Market Value (US$ Bn) Analysis 2017-2021 and Forecast 2022–2032, By Country

Table 06: North America Market Value (US$ Bn) Analysis and Opportunity Assessment 2017–2032, By Product Type

Table 07: North America Market Value (US$ Bn) Analysis and Opportunity Assessment 2017–2032, By Age Group

Table 08: North America Market Value (US$ Bn) Analysis- and Opportunity Assessment 2017–2032, By Distribution Channel

Table 09: Latin America Market Value (US$ Bn) Analysis 2017-2021 and Forecast 2022–2032, By Country

Table 10: Latin America Market Value (US$ Bn) Analysis and Opportunity Assessment 2017–2032, By Product Type

Table 11: Latin America Market Value (US$ Bn) Analysis and Opportunity Assessment 2017–2032, By Age Group

Table 12: Latin America Market Value (US$ Bn) Analysis- and Opportunity Assessment 2017–2032, By Distribution Channel

Table 13: Europe Market Value (US$ Bn) Analysis 2017-2021 and Forecast 2022–2032, By Country

Table 14: Europe Market Value (US$ Bn) Analysis and Opportunity Assessment 2017–2032, By Product Type

Table 15: Europe Market Value (US$ Bn) Analysis and Opportunity Assessment 2017–2032, By Age Group

Table 16: Europe Market Value (US$ Bn) Analysis- and Opportunity Assessment 2017–2032, By Distribution Channel

Table 17: South Asia Market Value (US$ Bn) Analysis 2017-2021 and Forecast 2022–2032, By Country

Table 18: South Asia Market Value (US$ Bn) Analysis and Opportunity Assessment 2017–2032, By Product Type

Table 19: South Asia Market Value (US$ Bn) Analysis and Opportunity Assessment 2017–2032, By Age Group

Table 20: South Asia Market Value (US$ Bn) Analysis- and Opportunity Assessment 2017–2032, By Distribution Channel

Table 21: East Asia Market Value (US$ Bn) Analysis 2017-2021 and Forecast 2022–2032, By Country

Table 22: East Asia Market Value (US$ Bn) Analysis and Opportunity Assessment 2017–2032, By Product Type

Table 23: East Asia Market Value (US$ Bn) Analysis and Opportunity Assessment 2017–2032, By Age Group

Table 24: East Asia Market Value (US$ Bn) Analysis- and Opportunity Assessment 2017–2032, By Distribution Channel

Table 25: Oceania Market Value (US$ Bn) Analysis 2017-2021 and Forecast 2022–2032, By Country

Table 26: Oceania Market Value (US$ Bn) Analysis and Opportunity Assessment 2017–2032, By Product Type

Table 27: Oceania Market Value (US$ Bn) Analysis and Opportunity Assessment 2017–2032, By Age Group

Table 28: Oceania Market Value (US$ Bn) Analysis- and Opportunity Assessment 2017–2032, By Distribution Channel

Table 29: MEA Market Value (US$ Bn) Analysis 2017-2021 and Forecast 2022–2032, By Country

Table 30: MEA Market Value (US$ Bn) Analysis and Opportunity Assessment 2017–2032, By Product Type

Table 31: MEA Market Value (US$ Bn) Analysis and Opportunity Assessment 2017–2032, By Age Group

Table 32: MEA Market Value (US$ Bn) Analysis- and Opportunity Assessment 2017–2032, By Distribution Channel

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 01: Global Market Value Analysis (US$ Bn), 2017-2021

Figure 02: Global Market Value Forecast (US$ Bn), 2022–2032

Figure 03: Global Market Absolute $ Opportunity, 2022 - 2032

Figure 04: Global Market Share Analysis (%), By Product Type, 2022 & 2032

Figure 05: Global Market Y-o-Y Analysis (%), By Product Type, 2022–2032

Figure 06: Global Market Attractiveness Analysis by Product Type, 2022–2032

Figure 07: Global Market Share Analysis (%), By Age Group, 2022 & 2032

Figure 08: Global Market Y-o-Y Analysis (%), By Age Group, 2022–2032

Figure 09: Global Market Attractiveness Analysis By Age Group, 2022–2032

Figure 10: Global Market Share Analysis (%), By Distribution Channel, 2022 & 2032

Figure 11: Global Market Y-o-Y Analysis (%), By Distribution Channel, 2022–2032

Figure 12: Global Market Attractiveness Analysis By Distribution Channel, 2022–2032

Figure 13: Global Market Share Analysis (%), By Region , 2022 & 2032

Figure 14: Global Market Y-o-Y Analysis (%), By Country, 2022–2032

Figure 15: Global Market Attractiveness Analysis by Region, 2022–2032

Figure 16: North America Market Value Share, By Product Type, 2022 (E)

Figure 17: North America Market Value Share, By Age Group, 2022 (E)

Figure 18: North America Market Value Share, By Distribution Channel, 2022 (E)

Figure 19: North America Market Value Share, By Country, 2022 (E)

Figure 20: North America Market Value Analysis (US$ Bn), 2017-2021

Figure 21: North America Market Value Forecast (US$ Bn), 2022–2032

Figure 22: North America Market Attractiveness Analysis by Product Type, 2022–2032

Figure 23: North America Market Attractiveness Analysis by Age Group, 2022–2032

Figure 24: North America Market Attractiveness Analysis By Distribution Channel, 2022–2032

Figure 25: North America Market Attractiveness Analysis By Country, 2022–2032

Figure 26: U.S. Market Value Proportion Analysis, 2022

Figure 27: Global Vs. U.S. Growth Comparison

Figure 28: U.S. Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 29: U.S. Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 30: U.S. Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 31: Canada Market Value Proportion Analysis, 2022

Figure 32: Global Vs. Canada Growth Comparison

Figure 33: Canada Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 34: Canada Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 35: Canada Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 36: Latin America Market Value Share, By Product Type, 2022 (E)

Figure 37: Latin America Market Value Share, By Age Group, 2022 (E)

Figure 38: Latin America Market Value Share, By Distribution Channel, 2022 (E)

Figure 39: Latin America Market Value Share, By Country, 2022 (E)

Figure 40: Latin America Market Value Analysis (US$ Bn), 2017-2021

Figure 41: Latin America Market Value Forecast (US$ Bn), 2022–2032

Figure 42: Latin America Market Attractiveness Analysis by Product Type, 2022–2032

Figure 43: Latin America Market Attractiveness Analysis by Age Group, 2022–2032

Figure 44: Latin America Market Attractiveness Analysis By Distribution Channel, 2022–2032

Figure 45: Latin America Market Attractiveness Analysis By Country, 2022–2032

Figure 46: Brazil Market Value Proportion Analysis, 2022

Figure 47: Global Vs. Brazil Growth Comparison

Figure 48: Brazil Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 49: Brazil Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 50: Brazil Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 51: Mexico Market Value Proportion Analysis, 2022

Figure 52: Global Vs. Mexico Growth Comparison

Figure 53: Mexico Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 54: Mexico Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 55: Mexico Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 56: Europe Market Value Share, By Product Type, 2022 (E)

Figure 57: Europe Market Value Share, By Age Group, 2022 (E)

Figure 58: Europe Market Value Share, By Distribution Channel, 2022 (E)

Figure 59: Europe Market Value Share, By Country, 2022 (E)

Figure 60: Europe Market Value Analysis (US$ Bn), 2017-2021

Figure 61: Europe Market Value Forecast (US$ Bn), 2022–2032

Figure 62: Europe Market Attractiveness Analysis by Product Type, 2022–2032

Figure 63: Europe Market Attractiveness Analysis by Age Group, 2022–2032

Figure 64: Europe Market Attractiveness Analysis By Distribution Channel, 2022–2032

Figure 65: Europe Market Attractiveness Analysis By Country, 2022–2032

Figure 66: U.K. Market Value Proportion Analysis, 2022

Figure 67: Global Vs. U.K. Growth Comparison

Figure 68: U.K. Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 69: U.K. Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 70: U.K. Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 71: France Market Value Proportion Analysis, 2022

Figure 72: Global Vs. France Growth Comparison

Figure 73: France Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 74: France Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 75: France Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 76: Germany Market Value Proportion Analysis, 2022

Figure 77: Global Vs. Germany Growth Comparison

Figure 78: Germany Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 79: Germany Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 80: Germany Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 81: Italy Market Value Proportion Analysis, 2022

Figure 82: Global Vs. Italy Growth Comparison

Figure 83: Italy Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 84: Italy Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 85: Italy Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 86: Spain Market Value Proportion Analysis, 2022

Figure 87: Global Vs. Spain Growth Comparison

Figure 88: Spain Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 89: Spain Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 90: Spain Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 91: Russia Market Value Proportion Analysis, 2022

Figure 92: Global Vs. Russia Growth Comparison

Figure 93: Russia Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 94: Russia Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 95: Russia Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 96: Poland Market Value Proportion Analysis, 2022

Figure 97: Global Vs. Poland Growth Comparison

Figure 98: Poland Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 99: Poland Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 100: Poland Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 101: South Asia Market Value Share, By Product Type, 2022 (E)

Figure 102: South Asia Market Value Share, By Age Group, 2022 (E)

Figure 103: South Asia Market Value Share, By Distribution Channel, 2022 (E)

Figure 104: South Asia Market Value Share, By Country, 2022 (E)

Figure 105: South Asia Market Value Analysis (US$ Bn), 2017-2021

Figure 106: South Asia Market Value Forecast (US$ Bn), 2022–2032

Figure 107: South Asia Market Attractiveness Analysis by Product Type, 2022–2032

Figure 108: South Asia Market Attractiveness Analysis by Age Group, 2022–2032

Figure 109: South Asia Market Attractiveness Analysis By Distribution Channel, 2022–2032

Figure 110: South Asia Market Attractiveness Analysis By Country, 2022–2032

Figure 111: India Market Value Proportion Analysis, 2022

Figure 112: Global Vs. India Growth Comparison

Figure 113: India Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 114: India Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 115: India Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 116: Thailand Market Value Proportion Analysis, 2022

Figure 117: Global Vs. Thailand Growth Comparison

Figure 118: Thailand Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 119: Thailand Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 120: Thailand Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 121: Malaysia Market Value Proportion Analysis, 2022

Figure 122: Global Vs. Malaysia Growth Comparison

Figure 123: Malaysia Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 124: Malaysia Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 125: Malaysia Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 126: Indonesia Market Value Proportion Analysis, 2022

Figure 127: Global Vs. Indonesia Growth Comparison

Figure 128: Indonesia Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 129: Indonesia Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 130: Indonesia Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 131: East Asia Market Value Share, By Product Type, 2022 (E)

Figure 132: East Asia Market Value Share, By Age Group, 2022 (E)

Figure 133: East Asia Market Value Share, By Distribution Channel, 2022 (E)

Figure 134: East Asia Market Value Share, By Country, 2022 (E)

Figure 135: East Asia Market Value Analysis (US$ Bn), 2017-2021

Figure 136: East Asia Market Value Forecast (US$ Bn), 2022–2032

Figure 137: East Asia Market Attractiveness Analysis by Product Type, 2022–2032

Figure 138: East Asia Market Attractiveness Analysis by Age Group, 2022–2032

Figure 139: East Asia Market Attractiveness Analysis By Distribution Channel, 2022–2032

Figure 140: East Asia Market Attractiveness Analysis By Country, 2022–2032

Figure 141: China Market Value Proportion Analysis, 2022

Figure 142: Global Vs. China Growth Comparison

Figure 143: China Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 144: China Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 145: China Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 146: Japan Market Value Proportion Analysis, 2022

Figure 147: Global Vs. Japan Growth Comparison

Figure 148: Japan Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 149: Japan Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 150: Japan Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 151: South Korea Market Value Proportion Analysis, 2022

Figure 152: Global Vs. South Korea Growth Comparison

Figure 153: South Korea Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 154: South Korea Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 155: South Korea Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 156: Oceania Market Value Share, By Product Type, 2022 (E)

Figure 157: Oceania Market Value Share, By Age Group, 2022 (E)

Figure 158: Oceania Market Value Share, By Distribution Channel, 2022 (E)

Figure 159: Oceania Market Value Share, By Country, 2022 (E)

Figure 160: Oceania Market Value Analysis (US$ Bn), 2017-2021

Figure 161: Oceania Market Value Forecast (US$ Bn), 2022–2032

Figure 162: Oceania Market Attractiveness Analysis by Product Type, 2022–2032

Figure 163: Oceania Market Attractiveness Analysis by Age Group, 2022–2032

Figure 164: Oceania Market Attractiveness Analysis By Distribution Channel, 2022–2032

Figure 165: Oceania Market Attractiveness Analysis By Country, 2022–2032

Figure 166: Australia Market Value Proportion Analysis, 2022

Figure 167: Global Vs. Australia Growth Comparison

Figure 168: Australia Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 169: Australia Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 170: Australia Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 171: New Zealand Market Value Proportion Analysis, 2022

Figure 172: Global Vs. New Zealand Growth Comparison

Figure 173: New Zealand Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 174: New Zealand Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 175: New Zealand Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 176: MEA Market Value Share, By Product Type, 2022 (E)

Figure 177: MEA Market Value Share, By Age Group, 2022 (E)

Figure 178: MEA Market Value Share, By Distribution Channel, 2022 (E)

Figure 179: MEA Market Value Share, By Country, 2022 (E)

Figure 180: MEA Market Value Analysis (US$ Bn), 2017-2021

Figure 181: MEA Market Value Forecast (US$ Bn), 2022–2032

Figure 182: MEA Market Attractiveness Analysis by Product Type, 2022–2032

Figure 183: MEA Market Attractiveness Analysis by Age Group, 2022–2032

Figure 184: MEA Market Attractiveness Analysis By Distribution Channel, 2022–2032

Figure 185: MEA Market Attractiveness Analysis By Country, 2022–2032

Figure 186: Turkey Market Value Proportion Analysis, 2022

Figure 187: Global Vs. Turkey Growth Comparison

Figure 188: Turkey Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 189: Turkey Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 190: Turkey Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 191: GCC Countries Market Value Proportion Analysis, 2022

Figure 192: Global Vs. GCC Countries Growth Comparison

Figure 193: GCC Countries Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 194: GCC Countries Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 195: GCC Countries Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 196: North Africa Market Value Proportion Analysis, 2022

Figure 197: Global Vs. North Africa Growth Comparison

Figure 198: North Africa Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 199: North Africa Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 200: North Africa Market Share Analysis (%) by Distribution Channel, 2022 & 2032

Figure 201: South Africa Market Value Proportion Analysis, 2022

Figure 202: Global Vs. South Africa Growth Comparison

Figure 203: South Africa Market Share Analysis (%) By Product Type, 2022 & 2032

Figure 204: South Africa Market Share Analysis (%) by Age Group, 2022 & 2032

Figure 205: South Africa Market Share Analysis (%) by Distribution Channel, 2022 & 2032